Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Using Pharmacogenetics to Identify Patients With Polypharmacy at Risk of Medication Adverse Effects

NCT03748355 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03748355
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03748355 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Using Pharmacogenetics to Identify Patients With Polypharmacy at Risk of Medication Adverse Effects
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Completed
Start date
October 14, 2018
Completion date
January 2, 2020
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psychiatric disorder